Fuda Cancer Hospital
Fuda Cancer Hospital
Cina, Canton
| Cina | Turchia | Austria | |
| Terapia ormonale | da $3,500 | da $406 | da $7,000 |
| Terapia con Actinio-225 | da $13,800 | da $22,955 | da $55,000 |
| Radioterapia per il cancro colorettale | da $11,500 | da $7,000 | da $12,000 |
| Ooforectomia | da $7,800 | da $2,943 | da $15,000 |
| Omentectomia | da $6,500 | da $4,500 | da $15,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Cancro ovarico. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Cancro ovarico e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Cancro ovarico.
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
Ovarian cancer treatment in China integrates cytoreductive surgery with platinum-based chemotherapy and maintenance therapies. Specialized centers combine Western protocols with Traditional Chinese Medicine to manage side effects. Advanced options like HIPEC, CyberKnife M6 radiosurgery, and Natural Killer cell therapy are available for complex or recurrent cases.
Bookimed Expert Insight: China is a global leader in combining traditional hospital stays with high-tech outpatient oncology. A package at Jinshazhou Hospital of Guangzhou University of Chinese Medicine costs approximately $7,750 for CyberKnife M6. This includes transfers and medications but excludes hospital nights. This model allows patients to receive advanced radiation while staying in more comfortable local accommodations.
Patient Consensus: Patients emphasize the importance of early genetic testing for BRCA status to access targeted therapies. Many note that high-volume hospitals in Guangzhou offer shorter wait times than public facilities in other regions.
Innovative maintenance therapies for ovarian cancer in China focus on targeted agents and cellular treatments. These include PARP inhibitors like olaparib and niraparib to repair DNA gaps. Anti-angiogenesis inhibitors and novel immunotherapies, including NK cell therapy, are also used within JCI-accredited facilities.
Bookimed Expert Insight: Genetic testing for BRCA and HRD markers is essential before selecting maintenance protocols. Chinese-manufactured PARP inhibitors offer similar efficacy to international brands at approximately 30% of the cost. Patients should verify if their package includes genomic profiling to ensure the therapy fits their profile.
Patient Consensus: Patients highlight that starting maintenance post-chemotherapy and managing fatigue are vital for long-term health. Many emphasize tracking CA-125 levels monthly to adjust therapy quickly if indicators change.
China offers advanced minimally invasive treatments for ovarian cancer, including NanoKnife (irreversible electroporation), cryosurgery, and microwave hyperthermal therapy. Specialized centers utilize CyberKnife M6 radiosurgery and DaVinci robotic systems for precise tumor removal. These ablative techniques target diseased tissue while preserving healthy surrounding organs.
Bookimed Expert Insight: While many countries focus on traditional debulking, Chinese JCI-accredited facilities like Fuda Cancer Hospital specialize in combining multiple minimally invasive therapies. Our data shows these centers often treat late-stage cases using a `3C` approach: cryosurgery, cancer microvascular intervention, and combined immunotherapy. This multimodal strategy is aimed at patients who are not candidates for conventional open surgery.
Patient Consensus: Patients note that while recovery from these ablative procedures is often faster than traditional surgery, it is vital to confirm long-term data. Some emphasize that these `miracle` options require careful screening to ensure they suit specific cancer stages.
The 5-year survival rate for ovarian cancer in China is approximately 43.7% in top centers. This baseline varies by cancer stage and patient age. Pediatric and adolescent cases show higher survival reaching 77.2%. Urban oncology centers consistently report better outcomes than rural facilities.
Bookimed Expert Insight: Patient volume is a major indicator of quality in Chinese oncology. Fuda Cancer Hospital serves over 30,000 patients from 100 countries. This high volume allows surgeons to master specific skills like cryosurgery. A CyberKnife M6 package from Jinshazhou Hospital costs approximately $7,750 (56,000 CNY). These bundles often include VIP transfers and doctor consultations which streamline complex medical travel.
Patient Consensus: Patients note that arriving at a specialized center quickly is vital for success. Many travelers recommend verifying a surgeon's specific volume in procedures like debulking before starting treatment.
International patients should plan to stay in China for 2 to 4 weeks after ovarian cancer surgery. This duration ensures initial wound stability and proper recovery. Most patients require 5 to 10 days of hospitalization. A further 14 days of local monitoring helps prevent complications for long-haul travel.
Bookimed Expert Insight: JCI-accredited facilities like Fuda Cancer Hospital focus on minimally invasive therapies that often reduce recovery times. While standard surgery requires a long stay, CyberKnife M6 packages available in Guangzhou include hotel stays and transfers. This coordination helps patients manage the transition from clinical care to travel readiness without logistical delays.
Patient Consensus: Patients note that hospitals may discharge you within 10 days. They emphasize booking a hotel nearby for another 2 weeks to handle follow-up care and pain management before flying home.
Medical tourism treatment packages bundle clinical procedures with essential travel logistics. They typically include surgery or radiosurgery, professional medical fees, and hospital facility charges. Most comprehensive options also provide ground transportation, bilingual coordination, and local accommodation to ensure a seamless healthcare experience.
Bookimed Expert Insight: China's leading oncology centers often prioritize specialized technology over standard hotel inclusions. For example, Jinshazhou Hospital offers advanced CyberKnife M6 radiosurgery with clinic transfers. However, their 56,000 CNY (approximately $7,850) oncology packages may not include hotel nights. Always check if accommodation is bundled or offered as an add-on.
Patient Consensus: Patients note it is important to budget extra for unexpected scans or extended recovery days. Many suggest getting all inclusions in writing to avoid surprises after arrival.
Identifying a high-quality cancer hospital in China requires selecting Grade 3-A institutions or JCI-accredited centers in medical hubs like Guangzhou, Beijing, or Shanghai. Prioritize facilities specializing in advanced oncology services, including robotic surgery, HIPEC, and minimally invasive treatments like cryosurgery or NanoKnife.
Bookimed Expert Insight: While public Tier-1 hospitals are excellent, international patients often face long admission waitlists. Data shows JCI-accredited facilities in Guangzhou, like Fuda Cancer Hospital, cater specifically to global arrivals with dedicated coordination. Choosing a clinic that offers bundled packages, such as Jinshazhou Hospital’s CyberKnife program for approximately $7,800, often includes necessary transfers and hotel stays that public hospitals rarely provide.
Patient Consensus: Patients emphasize choosing top-tier public hospitals in major cities to avoid quality variations. Many suggest hiring a personal translator for smoother navigation even within international departments.